The Senate Health, Education, Labor and Pensions (HELP) Committee approved a measure Wednesday designed to speed the approval of Ebola drugs. The bill (S. 2917) would make Ebola treatments eligible for priority review vouchers at the Food and Drug Administration (FDA), cutting down on the evaluation time taken by regulators. “As the U.S. continues to respond to Ebola, it is critical that we are doing all we can to get life-saving treatments...